Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat.
Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat.
复制标题
下丘脑肽激素的结构活性关系研究III.
DOI:
10.1016/0028-3908(82)90084-3
复制
发表时间:
1982
影响因子:
4.7
通讯作者:
Kim,HS
中科院分区:
文献类型:
--
作者:
Bhargava,HN;Kim,HS
The effects of several analogs of melanotropin-release inhibiting factor (MIF, Pro-Leu-Gly-NH2) on the development of tolerance to the hyperthermic, hypothermic and cataleptic actions of morphine were investigated in male Sprague-Dawley rats. The analogs that were examined included, Pro-Gly-Gly-NH2(I), Pro-Val-Gly-NH2(II), Pro-Leu-β-Ala-NH2, (III), Pro-Leu-Gly-NHCH3(IV), Pro-Leu-NH2(V) and cyclo (Pro-Gly) (VI). Subcutaneous implantation of four morphine pellets (each containing 75 mg of morphine free base) during a 3-day period was used to develop tolerance to the pharmacological effects of morphine. Concurrent daily subcutaneous administration of any of the above peptides (IthroughVI) at a 10 μ mol/kg dose did not modify the development of tolerance to morphine-induced hyperthermia, hypothermia or catalepsy. The development of tolerance to morphine was, however, inhibited by equivalent doses of MIF. Treatment with these peptides did not alter the distribution of morphine in brain and plasma. It is concluded that the structural requirements for the inhibitory effect of MIF on the development of tolerance to morphine are very strict and that the following modifications in the structure of MIF result in the loss of activity (a) substitution of Gly or Val in place of Leu (b) replacement of Gly-NH2with Gly-NHCH3or β-Ala-NH2(c) removal of Gly, and (d) removal of Leu followed by cyclization of Pro-Gly.